Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...
The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device ...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson (MCK) concluded the recent trading session at $585.08, signifying a +0.57% move from its prior day's close.